Stephen Mandel Moderna, Inc. Transaction History

Lone Pine Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $24 Million - $34.9 Million	177,100 Added 13.09%	1,529,618 $235 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $160 Million - $284 Million	1,352,518 New	1,352,518 $243 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $749 Million - $1.22 Billion	-3,316,199 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $150 Million - $327 Million	-674,698 Reduced 16.91%	3,316,199 $1.28 Billion
Q2 2021 Aug 16, 2021	BUY	$129.91 - $234.98 $518 Million - $938 Million	3,990,897 New	3,990,897 $938 Million

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Lone Pine Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lone Pine Capital LLC and Stephen Mandel with notifications on news.